# Rilonacept for Treatment of Familial Mediterranean Fever (FMF)

> **NCT00582907** · PHASE2 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 14 (actual)

## Conditions studied

- Familial Mediterranean Fever

## Interventions

- **DRUG:** Rilonacept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00582907
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00582907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00582907, "Rilonacept for Treatment of Familial Mediterranean Fever (FMF)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00582907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*